Tomorrow must be a big rebound.

HWATAi is the next
genetec (0104).

It is certain that it will return to the previous 1.60 later.

Today there is a chance to limit up.

SALUTICA BERHAD
(201201040303) (1024781-T)
(Incorporated in Malaysia)
SUMMARY OF THE KEY MATTERS DISCUSSED AT THE 8TH ANNUAL GENERAL MEETING
(“8TH AGM”) OF THE COMPANY HELD ON MONDAY, 23 NOVEMBER 2020
Question 1:
What would Management expect for coming year 2021 performance? Would the Company still
make loss due to project still under Research & Development (“R&D”) stage?
The Company’s response:
As the Company is listed in the Bursa Malaysia Securities Berhad, we do not provide profit
forecasts.
The impact of the COVID-19 pandemic would persist into next year and inspite the uncertainties
in the global environment, the Group’s R&D team would continue to focus on the timely realisation
of several planned new products. However, the Group performance would depend on consumers’
responses.
Question 2:
Why has the employee cost increased so much from RM25.957 million to RM30.628 million?
Please also explain on the increased of receivables and stock from RM8.782 million to RM24.880
million and RM34.301 million to RM57.888 million respectively for the financial year ended 30 June
2020 as compared to the previous financial year? How is the progress of FOBO business? Is the
Company having any plan to do Bonus Issue?
The Company’s response:
Due to the increase in minimum wages to RM1,200.00 per month since February this year, it has
impact of direct cost increased by approximately RM0.3 million per month of the Group. Moreover,
the Group had halted its production during the Movement Control Order (“MCO) in March 2020
and resume 50% production in April 2020 which resulted in idle production costs of RM3.2 million.
The Group resumed full operation from 29 April 2020 onwards.
The increased in receivables was due to the higher sales recorded in the last 3 months before the
closing in June 2020. In tandem with the increased in orders, inventories have also increased in
preparation for the order fulfilment.
FOBO business has increased in the past 2 to 3 months. There were also new distributors for
FOBO brand in the United States and Japan which helps to promote growth for FOBO sales.
The Company would consider to undertake the Bonus Issue to reward the shareholders when the
time is right.

As the Company is listed in the Bursa Malaysia Securities Berhad, we do not provide profit
forecasts.
The impact of the COVID-19 pandemic would persist into next year and inspite the uncertainties
in the global environment, the Group’s R&D team would continue to focus on the timely realisation
of several planned new products. However, the Group performance would depend on consumers’
responses.
Question 2:
Why has the employee cost increased so much from RM25.957 million to RM30.628 million?
Please also explain on the increased of receivables and stock from RM8.782 million to RM24.880
million and RM34.301 million to RM57.888 million respectively for the financial year ended 30 June
2020 as compared to the previous financial year? How is the progress of FOBO business? Is the
Company having any plan to do Bonus Issue?
The Company’s response:
Due to the increase in minimum wages to RM1,200.00 per month since February this year, it has
impact of direct cost increased by approximately RM0.3 million per month of the Group. Moreover,
the Group had halted its production during the Movement Control Order (“MCO) in March 2020
and resume 50% production in April 2020 which resulted in idle production costs of RM3.2 million.
The Group resumed full operation from 29 April 2020 onwards.
The increased in receivables was due to the higher sales recorded in the last 3 months before the
closing in June 2020. In tandem with the increased in orders, inventories have also increased in
preparation for the order fulfilment.
FOBO business has increased in the past 2 to 3 months. There were also new distributors for
FOBO brand in the United States and Japan which helps to promote growth for FOBO sales.
The Company would consider to undertake the Bonus Issue to reward the shareholders when the
time is right.

https://www.facebook.com/Jllioncapital/posts/191064892588562
可能是包含下列内容的图片：上面的文字是“如何从 科技板块 布局下一个 GENETEC GENETEC? JLLION CAPITAL Genetec”


可能是包含下列内容的图片：上面的文字是“CAPITAL APPASIA (0119) 下一个暴涨股？ 6月18日将1 股拆成3股， 每10张母股 送一张凭单B。 Dato Wira Rahadian Mahmud Bin Mohammad Khalil成为新股东 不断从公开市场回购公司股份 (share buy back) 凭单A大量转换成母股。 但凭单B在周 五做了非常大量， 盘面上比较不美。 股价在未拆分前一度推到最高9毛多 拆分后约3毛） 老板没有出货嫌疑。 ·基本面开始变美，转亏为盈连续4个季 基本面开始变美， 转亏为盈连续4个季 度有盈利。 从上述一系列企业动作中可以推断出¿ 家公司老板的企图心。 JLLION CAPITAL”
https://www.facebook.com/Jllioncapital/photos/pcb.367656788262704/367655684929481

CTOS数字出资1005万 购RAM控股4.6%股权
2021年07月29日
（吉隆坡29日讯）CTOS数字（CTOS，5301，主板科技股）掏出1005万令吉，从联昌国际（CIMB，1023，主板金融股）手中，认购大马评估机构控股（RAM）的4.6%股权。

CTOS数字周四发文告指出，已和联昌国际签署股权认购协议，以1005万令吉现金，买进RAM约46万股，相等于4.6%股份。

ADVERTISEMENT


该认购活动会在周四完成，同时，CTOS数字的债务也不会因此增加，因他们是利用首次公开售股筹集回来的资金来购股。

该公司也解释，通过此次认购，CTOS数字和RAM可利用彼此在信用评估、数据分析方面的专业知识，提供更优质服务予客户群。

“双方都将受惠于这项伙伴关系，和产生协同效益。”




CTOS数字总执行长丹尼斯马丁也说：“RAM是国内债券评级行业的领先者，他们有在经济、债券市场研究、数据分析方面提供一系列解决方案。”

“我们相信，未来双方会在产品、客户群方面存在巨大协同效益。”

CTOS, the pride and legacy of Creador



The CEO of Creador (Brihmal Vasudevan) (pic) did highlight that the firm intends to hold its stake for another five to 10 years. But this was back in 2014 when he envisaged a growth of 20% per annum and had targeted to grow SME clients to 15,000. It is now the seventh year since then and the SME clients today stand at 17,000 strong.

CTOS Digital Bhd closed its initial public offering (IPO) debut at RM1.62, which is 47% above its IPO price of RM 1.10. Considering the weak market sentiment amidst raging Covid-19 cases in the region and political uncertainty, I would say the IPO was a huge success.

In addition, we must note that the CTOS IPO offering was on the higher end of the valuation (45 times the price earnings ratio or PER). At today’s market price, it is trading at 68 times the forward PER. Calculated simplistically, it is expensive by any metrics.

However, what matters isn’t just the PER valuation of the business. There are certain qualitative factors to consider.

Prior to the IPO, I chose not to write about CTOS as there were many writers commenting on the stock across all forums. An additional opinion doesn’t matter as much.

What prompted me today, however, was because I noticed a brokerage’s telegram channel which was bullish on CTOS, directly encouraging retail investors to take position citing MR DIY’s IPO performance as a benchmark. I do not think this is a fair justification to invest in a stock.

MR DIY and CTOS are completely different sectors although they have the same private equity (PE) fund backer. Based on this rationale, as MR DIY’s share price went up close to three times from its IPO price, does it mean CTOS would also go up in the same quantum?

Many unknowing retail investors, especially those who are new to investing, may take it at face value and just plough into the stock. It is necessary to look at CTOS from various angles before making a decision, not just benchmarking a previous IPO performance.

CTOS in itself is a household name as most of our financial data is readily available or compiled by CTOS. Its usage is as close to a daily essential or necessity in the commercial world. I do not deny the near monopolistic position (market leader) of CTOS in Malaysia’s credit rating reporting sector gives it a shining halo.

If you look at CTOS from the lens of the credit rating reporting sector, it is in my humble view that CTOS is rather steep in valuation accorded by the market. There are other companies which are far more profitable and scalable with higher dividend yield or at least real returns for investors.

In short, it is expensive. To determine if CTOS is a viable investment, there is a need to also look beyond our shores for comparison of companies within the same sector, as Malaysia is after all a very small market.

The notable names in this sector are Experian Plc which is listed on the London Stock Exchange and Equifax Inc that is on the New York Stock Exchange. The table shows the valuation multiple and market capitalisation comparison of the companies within the space. You can see clearly, that against the bigger and more established names in the sector, CTOS is trading at a much higher valuation.

However, if you look at CTOS from the view of a fintech play or at least an important part of the fintech space (with digital bank development for Malaysia in the near future), then this is something else altogether.

It is similar to the electric vehicle (EV) space, whereby any stocks related to EV go crazy in terms of market interest and premium for its valuation. What I have learnt from the stock market in the past two years especially with the influx of millennial retail investors would be; they are willing to pay for a stock which is related to “theme of the future” regardless of the fundamentals.

Whether this is rational or not is a topic for another day. In addition, there is the plus point of scarcity premium and growth prospect considering CTOS has only started to embark on regional expansion.

Apart from looking at CTOS from the two lens mentioned above, an important perspective would be Creador’s role in the middle of all these. CTOS is not like MR DIY. It is the pride and legacy of this PE firm.

Early on in 2014, before Creador achieved today’s market reputation and status, Creador bought a 70% stake in CTOS Holdings for RM215mil in September 2014 through its second fund and later on another 10% stake at RM45mil (total RM260mil for an 80% shareholding).

Through the IPO, Creador offered 720 million shares (36%) for sale via the listing exercise. The fund pockets a cool RM792mil cash. This nets a gross gain of three times for the 36% stake alone.

Not forgetting the balance 40% stake (880 million shares post-enlarged issuance) which is at present day worth RM1.41bil. Let’s say Creador were to exit in full today, the PE fund would net a gross gain of RM1.94bil before

the game just begining

Waiting to rise.

There are few people selling, and those who want to buy cheaper will be disappointed.

It should be above 1.8 before the market closes.

Rebound before the market closes.

Buy bargain hunting is coming.

Maybe the performance will be tomorrow.

face： where you got that AE will apply ipo in usa?

QES in JV with US-based Applied Engineering to set up plant in Penang
TheStar Thu, Jul 15, 2021 01:40pm - 52 minutes ago



QES Group president Chew Ne Weng said being a JV partner, it will play its role to support this high technology equipment manufacturing project using its established networks across Asean, China and other parts of Asia for AET to expand from Malaysia

KUALA LUMPUR: QES Bhd is teaming up with US-based Applied Engineering (AE) to provide high-tech electromechanical contract manufacturing services in Batu Kawan Industrial Park, Penang.

Both parties had signed an agreement to set up the JV company, Applied Engineering Technology (M) Sdn Bhd (AET) to provide the services which range from prototyping to high volume production, according to a joint statement on Thursday.

The JV will cater to the specific needs of clients in the semiconductor equipment manufacturing, life science and medical devices, defence, and aerospace market segments, not only in Malaysia, but also to Asean countries and China.

The proposed initial investment for AET is about RM5mil with an initial workforce of 20 workers, comprising mainly engineers and technicians. The investment is set to expand up to RM20mil over the next three years.

AET looks to kick-start its operations in a temporary premise before moving to its new factory in Batu Kawan Industrial Park during the fourth quarter of 2022.

Malaysian Investment Development Authority (MIDA) CEO Arham Abdul Rahman said the electrical and electronics (E&E) and related services industries continue to assume a critical role in Malaysia’s industrial development.

He said they are part of the critical global supply chain and ecosystem to support other high technology industries.

“MIDA is optimistic that AE’s presence here will further boost the development of our high technology equipment ecosystem, enable more opportunities for our local vendors and spur high-employment for Malaysians,” he said.

AE president Jack Yao said MIDA had been crucial in enabling both companies to come together to set up the JV.

“Malaysia will provide the launching pad to AE’s strategical move to expand outside USA to service its major customers in Malaysia and the Asia Pacific.

AE will bring its latest generation of high-end technologies to Malaysia and builds up a whole new technology sector. A significant number of R&D activities are also planned for this new location. Malaysia can benefit its position as a technology-country and can strengthen the region as a high-tech manufacturing hub in Asia Pacific.”

QES Group president Chew Ne Weng said being a JV partner, it will play its role to support this high technology equipment manufacturing project using its established networks across Asean, China and other parts of Asia for AET to expand from Malaysia.

“QES hopes to leverage the well-established and technical strength of AE to further improve our manufacturing capabilities. Together with MIDA, QES anticipates AET will create a sustainable high technology equipment manufacturing eco-system within E&E and medical segments for Malaysia,” said Chew.

It's different in the afternoon.

Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
YBS INTERNATIONAL BERHAD

Particulars of substantial Securities Holder
Name MUSHARAKA TECH VENTURE SDN BHD
Address 9-2 Block C Platinum Walk,
2 Jalan Langkawi Setapak,
53300 Kuala Lumpur
Company No. 200701006822 (764823-T)
Nationality/Country of incorporation Malaysia
Descriptions (Class) Ordinary Share
Details of changes
No Date of change
No of securities
Type of Transaction Nature of Interest
1 09 Jul 2021
400,000
Disposed Direct Interest
Name of registered holder Musharaka Tech Venture Sdn Bhd
Address of registered holder 9-2 Block C Platinum Walk, 2 Jalan Langkawi Setapak, 53300 Kuala Lumpur
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred Disposal through Open Market
Nature of interest Direct Interest
Direct (units) 22,674,200
Direct (%) 9.201
Indirect/deemed interest (units) 0
Indirect/deemed interest (%) 0
Total no of securities after change 22,674,200
Date of notice 12 Jul 2021
Date notice received by Listed Issuer 12 Jul 2021


Announcement Info
Company Name YBS INTERNATIONAL BERHAD
Stock Name YBS
Date Announced 12 Jul 2021
Category Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016
Reference Number CS2-08072021-00132

next GENETEC (0104)

dimmubroker …If the major shareholders buy again, it is easy to achieve.

show time is next Monday.

There is a chance to exceed RM2 this week.

limit up is coming.

It will rebound in the afternoon or tomorrow.

https://www.facebook.com/100414095066894/posts/323432219431746/?sfnsn=mo

Here comes the opportunity to buy.

After the cancellation of the bonus share plan, the board of directors may consider other corporate activities to increase shareholder value and will announce it in due course.
The second one like GENETEC (0104) is here.

heard that the stock price will return to the previous RM5.

Will it rise like (Samaiden)?

It's like limit up is coming.

This counter also has major news to be announced, but the time has not yet arrived

Now it's just waiting for an opportunity to rush up.

It will be over 0.6 today.

The boss of PMETAL (8869) started to take action.

start to rise tomorrow.

show time

show time

can limit up today.

limit up is coming.

(ipmuda 5673) will be the next (tocean (7218).

Be careful. It's starting to fall.

Tomorrow it will be (UCREST BHD) limit up.

tp1：40 sen，tp2：60sen

heard it was bonus issue?

Today there is a chance to limit up.

升利吉呼吸辅助器研发完成
Sinchew Sun, May 16, 2021 01:28pm - 19 hours ago




（古来15日讯）升利吉科技（SANICHI,0133,创业板工业组）完成呼吸辅助器产品的医疗用研究及开发工作，准备供应呼吸辅助器给本地和海外医疗保健市场。

等待当局批准执照

该公司发文告表示，呼吸辅助器的原型已完成，目前正向有关当局申请所需的执照，并等待批准。

升利吉科技预测，将在6个月后大规模生产呼吸辅助器，并进行分销。

董事经理拿督斯里彭兆发表示，集团开发呼吸器时机引非常合时宜，全球冠病确诊人数暴增，对呼吸器的需求明显增加。目前我们已向有关当局申请所需的执照和准准证。我们希望可以尽早进行大规模生产呼吸辅助器，以迎合本地和国际市场需求。

“大马有2.1%人口完成疫苗接种，但是新增确诊人数却是与日俱增。

我们深切了解，即使在国内也需要用到大量呼吸器，主要是ICU病房的人数大增，因此真诚希望我们推出的呼吸器可以减缓国家的紧急需求。”

全球呼吸辅助器的市场规模预测由2019年的10亿5000万美元，到2027年将增长30亿2000万美元，每年复成长率达到13.96%。随著全球冠病确诊人数增至1亿5800万人，呼吸辅助器的需求会进一步提高。

一旦获得所需批文，升利吉科技就会马上在国内市场分销呼吸辅助器，同时会出口至其他亚太国家市场，并会扩展至欧洲及美国市场。

This counter will distribute bonus issue.

limit up before the market closes.